From The Public Discourse:
The ideology glorified by “Pride” month has overtaken much of the
medical profession. Burgeoning numbers of trans-identifying individuals
demand euphemistically labeled “gender affirming treatment,” or GAT
(puberty-blocking drugs, cross-sex hormones, surgeries), and clinicians
in the thriving trans industry are often happy to provide it.
At the very least in this experimental area of medicine, these
professionals should be scrupulous about obtaining truly informed
consent before proceeding. Informed consent is the process by which
physicians educate patients about the risks and alternatives of a
medical intervention, to ensure that patients can fully understand and
consent to the path chosen.
But in too many cases, this critical process that protects the
dignity and authority of the patient is not happening. The
marginalization of informed consent is contributing to the worst ethical scandal in the medical profession
since the lobotomy craze ended in the mid-twentieth century. One hopes
that this latest scandal will lead to an end to this dark chapter in the
profession.
Dr. Steven B. Levine, professor of psychiatry at Case Western Reserve
University, focuses on treating trans-identifying children and
adolescents and has written extensively (see here and here) about the nature of informed consent for such patients. (In 2020, I discussed this work for Public Discourse in a two–part essay.) Although Levine, unlike many physicians,
does not rule out GAT in all circumstances, he recognizes that medical
interventions for gender dysphoria or incongruence profoundly implicate
many aspects of a patient’s life: physical and mental health, social
adjustment, family relationships, and romantic relationships. Decisions
made now will determine whether the young patient ultimately flourishes
or flounders.
Building on his earlier work, a new study by Levine and his
colleagues E. Abbruzzese and Julia W. Mason, published in March 2022,
finds that the informed-consent process is too often more of a
box-checking exercise than a serious discussion and deliberation. In “Reconsidering Informed Consent for Trans-Identified Children, Adolescents, and Young Adults,”
the authors (to whom I will refer as “Levine” for short) lament that
clinicians in the trans industry have gone beyond simple negligence or
incompetence; instead, they are engaging in demonstrably unethical
practices. (Read more.)
Share